We are proud to share this article from T1D Strong featuring pediatric endocrinologist, researcher, and associate professor Dr. Laura Jacobsen, who also serves as TrialNet’s Pathway to Prevention Study Chair. Dr. Jacobsen’s advocacy for prevention research and enrollment in clinical trials has advanced TrialNet’s early-stage T1D screening efforts, which have already reached 250,000 people worldwide.
To learn more about TrialNet’s 25-year legacy of early detection awareness and prevention research, and how devoted scientists like Dr. Jacobsen are continuing to revolutionize Type 1 diabetes treatment, read the full article below.
